| Primary |
| Bipolar Disorder |
36.5% |
| Drug Use For Unknown Indication |
33.4% |
| Epilepsy |
14.9% |
| Depression |
6.4% |
| Partial Seizures |
1.5% |
| Anxiety |
1.1% |
| Mood Swings |
0.8% |
| Asthma |
0.7% |
| Convulsion |
0.7% |
| Headache |
0.7% |
| Bipolar Ii Disorder |
0.5% |
| Contraception |
0.5% |
| Convulsion Prophylaxis |
0.3% |
| Migraine |
0.3% |
| Multiple Allergies |
0.3% |
| Sleep Disorder |
0.3% |
| Temporal Lobe Epilepsy |
0.3% |
| Attention Deficit/hyperactivity Disorder |
0.2% |
| Bipolar I Disorder |
0.2% |
| Blood Pressure |
0.2% |
|
| Rash |
36.5% |
| Stevens-johnson Syndrome |
7.0% |
| Drug Ineffective |
4.9% |
| Convulsion |
4.7% |
| Urticaria |
4.5% |
| Vision Blurred |
3.8% |
| Tremor |
3.6% |
| Vomiting |
3.6% |
| Alopecia |
3.1% |
| Drug Exposure During Pregnancy |
3.1% |
| Somnolence |
3.1% |
| Insomnia |
2.9% |
| Weight Increased |
2.9% |
| Pruritus |
2.7% |
| Rash Papular |
2.7% |
| Drug Screen Positive |
2.2% |
| Nausea |
2.2% |
| Rash Generalised |
2.2% |
| Live Birth |
2.0% |
| Rash Pruritic |
2.0% |
|
| Secondary |
| Temporal Lobe Epilepsy |
24.5% |
| Drug Use For Unknown Indication |
15.3% |
| Epilepsy |
14.3% |
| Bipolar Disorder |
13.3% |
| Depression |
12.2% |
| Drug Exposure During Pregnancy |
6.1% |
| Onychomycosis |
2.0% |
| Partial Seizures |
2.0% |
| Prophylaxis |
2.0% |
| Convulsion |
1.0% |
| Fibromyalgia |
1.0% |
| Glioblastoma |
1.0% |
| Hypercholesterolaemia |
1.0% |
| Immunisation |
1.0% |
| Pyrexia |
1.0% |
| Sleep Disorder |
1.0% |
| Therapeutic Procedure |
1.0% |
|
| White Blood Cell Count Decreased |
23.5% |
| Rash |
8.8% |
| Toxic Epidermal Necrolysis |
8.8% |
| Convulsion |
5.9% |
| Tremor |
5.9% |
| Vomiting |
5.9% |
| Accident |
2.9% |
| Bone Marrow Failure |
2.9% |
| Epilepsy |
2.9% |
| Haemorrhage |
2.9% |
| Headache |
2.9% |
| Liver Function Test Abnormal |
2.9% |
| Meconium In Amniotic Fluid |
2.9% |
| Muscle Twitching |
2.9% |
| Neck Pain |
2.9% |
| Partial Seizures |
2.9% |
| Pre-eclampsia |
2.9% |
| Premature Baby |
2.9% |
| Product Quality Issue |
2.9% |
| Rash Macular |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.6% |
| Bipolar Disorder |
13.5% |
| Depression |
10.5% |
| Epilepsy |
7.1% |
| Convulsion |
5.4% |
| Crohn's Disease |
5.1% |
| Schizoaffective Disorder |
4.7% |
| Pain |
4.4% |
| Bipolar I Disorder |
4.1% |
| Anxiety |
3.7% |
| Asthma |
3.7% |
| Insomnia |
3.0% |
| Fibromyalgia |
2.7% |
| Multiple Sclerosis |
2.7% |
| Emphysema |
2.4% |
| Hypertension |
2.4% |
| Mania |
2.4% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Trigeminal Neuralgia |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
|
| Weight Increased |
11.6% |
| Epilepsy |
10.1% |
| Type 2 Diabetes Mellitus |
8.7% |
| Tremor |
7.2% |
| Vomiting |
7.2% |
| Suicide Attempt |
5.8% |
| Vision Blurred |
5.8% |
| Somnolence |
4.3% |
| Throat Tightness |
4.3% |
| Vertigo |
4.3% |
| Weight Decreased |
4.3% |
| Convulsion |
2.9% |
| Drug Ineffective |
2.9% |
| Dyspnoea |
2.9% |
| Galactorrhoea |
2.9% |
| Ileus |
2.9% |
| Palpitations |
2.9% |
| Pharyngeal Hypoaesthesia |
2.9% |
| Pneumonia |
2.9% |
| Rhabdomyolysis |
2.9% |
|
| Interacting |
| Tendonitis |
75.0% |
| Bacterial Disease Carrier |
25.0% |
|
|
